Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 602

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 1
Chunk 602
---
 employees have not effectively waived the right to compensation with respect to inventions that they helped create,
they may be able to assert claims for compensation with respect to our future revenue may be successful. As a result, we may receive less
revenue from future products if such claims are successful which in turn could impact our future profitability.

64

Changes in U.S. patent law
could diminish the value of patents in general, thereby impairing our ability to protect our products.

As is the case with other biopharmaceutical
companies, our success is heavily dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biotechnology
industry involves both technological and legal complexity. Therefore, obtaining and enforcing biotechnology patents is costly, time-consuming
and inherently uncertain. In addition, the U.S. has recently enacted and is currently implementing wide-ranging patent reform legislation.
Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights
of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future,
this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on future actions by
the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that
would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future.

We may not be able to protect our intellectual
property rights throughout the world.

Filing, prosecuting and defending
patents on our approved product or product candidates in all countries throughout the world would be prohibitively expensive, and our
intellectual property rights in some countries outside the U.S. can be less extensive than those in the U.S. In addition, the laws of
some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the U.S.

Competitors may use our technologies
in jurisdictions where we have not obtained patent protection to develop their own products and may also export otherwise infringing products
to territories where we have patent protection, but enforcement is not as strong as that in the U.S. These products may compete with our
products and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.

Many companies have encountered
significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries,
particularly certain developing countries, do not favor the enforcement